|Day Low/High||130.65 / 131.75|
|52 Wk Low/High||113.52 / 174.00|
Here is my compilation of last night's profit reports. 24 beats: W&T Offshore (WTI) Oasis Petroleum (OAS) Marathon Oil (MRO) Huntington Ingalls Industries (HII) Cognizant Technology Solutions (CTSH) Disney (DIS) Electronic Arts (EA) Regency Centers ...
Jazz Pharmaceuticals, Parexel and HCA have made recent upside moves in heavy volume.
Brittany Umar and Scott Redler, chief strategic officer at T3Live.com, reveal how to trade stocks ahead of earnings season: retail, banks, tech.
Jazz and Questcor offer investors reasonable valuations in this area.
While the stock is still drifting lower, it is doing so on lighter volume, so I'll cover one-third of my short. Jazz Pharmaceuticals (JAZZ) continues to trade poorly after forming a head-and-shoulders pattern. I wrote about this in my April 13 colum...
I wouldn't be surprised to see JAZZ lose another 10% from here before finding support.
I'm flipping into strength and continuing to look for pockets of momentum.
The dip-buying is good but we need to see stronger momentum and better leadership.
There isn't necessarily any correlation between the way stocks trade and the feeling about the economy.
It's not that the market action is bad, it just isn't lively enough to support aggressive action.
Anticipation of a positive jobs report shows Wall Street edging higher in the early going.
We had great trades on the euro and the SPX, but we had some bad ones in FXF, SI and JAZZ.
Despite the solid performance so far this year, there's still time to get on board and ride the profit train.
If the market likes what it hears from the Fed, we could close above the important 1,219 level.
Anticipation of the Fed announcement is likely to keep bids in place and keep the selling from gaining momentum.
Its chart shows that buyers are becoming more aggressive than sellers.